蓝帆医疗股份有限公司关于预计触发可转债转股价格向下修正条件的提示性公告

Core Viewpoint - The company, BluFan Medical Co., Ltd., is expected to trigger the condition for a downward adjustment of the convertible bond conversion price due to its stock price being below 85% of the current conversion price for 10 trading days [2][12]. Group 1: Convertible Bond Issuance and Adjustment - The company issued 31,440,404 convertible bonds with a total value of 314.404 million yuan on May 28, 2020 [3]. - The convertible bonds were listed on the Shenzhen Stock Exchange on June 19, 2020, under the name "BluFan Convertible Bond" and code "128108" [4]. - The conversion period for the bonds is from December 3, 2020, to May 27, 2026 [5]. - The initial conversion price was set at 10.50 yuan per share [2]. Group 2: Conversion Price Adjustments - The conversion price has been adjusted multiple times due to various corporate actions, including performance compensation and profit distribution [6][7][8]. - The conversion price was adjusted from 17.79 yuan to 18.64 yuan on June 25, 2021, and subsequently to 18.24 yuan on July 7, 2021, and further to 17.84 yuan on May 31, 2023 [6][7][8]. - The most recent adjustment occurred on September 23, 2025, lowering the conversion price to 10.50 yuan per share [10]. Group 3: Trigger Conditions for Price Adjustment - The company is required to hold a board meeting to decide on the adjustment of the conversion price if the stock price remains below 85% of the conversion price for 10 trading days [12]. - The specific threshold for triggering the adjustment is set at 8.925 yuan per share, which is 85% of the current conversion price of 10.50 yuan [12].